Article Information
History
- June 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Freja C M Kirsebom, PhD1,*,
- Nick Andrews, PhD1,2,
- Anna A Mensah1,
- Julia Stowe, PhD1,
- Shamez N Ladhani, PhD1,3,
- Mary Ramsay, MBBS, FFPH1,2,
- Jamie Lopez Bernal, PhD, MBBS*,1,2,4 and
- Helen Campbell*,1
- 1UK Health Security Agency, London, United Kingdom
- 2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
- 3Infection and Immunity Division. St. George’s University of London, Cranmer Terrace, London SW17 0RE, UK
- 4NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
- ↵* Corresponding author; email: freja.kirsebom{at}ukhsa.gov.uk
Posted June 10, 2023.
Vaccine effectiveness against mild and severe disease in pregnant mothers and their infants in England
